Monitoring changes and predicting loss of ambulation in Duchenne muscular dystrophy with the Motor Function Measure
Vuillerot C, Girardot F, Payan C, Fermanian J, Iwaz J, de Lattre C, Bérard C.
Dev med Child Neurol 2009. 52(1): 60-65.
Changes in MFM scores of 12 DMD patients treated with corticosteroids and 54 without treatment. The results support the use of MFM in the treatment of patients with Duchenne muscular dystrophy and its use in clinical trials to evaluate patients receiving a therapy. The MFM also help to predict the loss of walk for patients with DMD.
Keywords: Duchenne Muscular Dystrophy, MFM, Corticosteroids, Loss of walk, Management of patients
Articles dans les revues scientifiques
The Use of Functional Scales for Clinical Evaluation of Duchenne Muscular Dystrophy
Barra TMF, Baraldi KF Revista Neurociências. 2013. 21(3):420-426. Literature review of scientific articles, books and dissertations published from 2000 to 2011, in Portuguese, English and Spanish languages to demonstrate the applicability of using Vignos scales, Egen...
Assisted bicycle training delays functional deterioration in boys with duchenne muscular dystrophy: the randomized controlled trial “no use is disuse”.
Jansen M, van Alfen N, Geurts AC, de Groot IJ. Neurorehabil Neural Repair. 2013. 27(9):816-27. Thirty boys (18 ambulant and 12 wheelchair-dependent) with a DMD were physically trained using an assisted bicycle. After 24 weeks, the total MFM score remained stable in...
Innovative methods to assess upper limb strength and function in non-ambulant Duchenne patients.
Servais L, Deconinck N, Moraux A, Benali M, Canal A, Van Parys F, Vereecke W, Wittevrongel S, Mayer M, Desguerre I, Maincent K, Themar-Noel C, Quijano-Roy S, Serari N, Voit T, Hogrel JY. Neuromuscul Disord. 2013. 23(2) : 139-48. Development of new tools to precisely...
Motor Function Measure: validation of a short form (MFM-20) for young children with neuromuscular diseases
Capucine de Lattre, Christine Payan, Carole Vuillerot, Pascal Rippert, Denis de Castro, Carole Bérard, Isabelle Poirot and the MFM-20 Study Group. Arch Phys Med Rehabil. 2013. 94 : 2218-26. Validation of MFM version useful in neuromuscular children under 7 years old,...
Responsiveness of the Motor Function Measure in Patients With Spinal Muscular Atrophy.
Vuillerot C, Payan C, Iwaz J, Ecochard R, Bérard C and the MFM Spinal Muscular Atrophy Study Group. Arch Phys Med Rehabil. 2013. 94(8) : 1555-61. Assessment in 112 patients with Spinal Muscular Atrophy (SMA) aged 5.7 to 59 years of the ability of the MFM to detect...
Quantitative MRI and loss of free ambulation in Duchenne muscular dystrophy.
Fischmann A, Hafner P, Gloor M, Schmid M, Klein A, Pohlman U, Waltz T, Gonzalez R, Haas T, Bieri O, Fischer D. J Neurol. 2013. 260(4):969-74. The purpose of this trial was to correlate quantitative MRI with functional abilities, evaluate using MFM in 22 ambulant or...